RNAC
Cartesian Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
3.52 / 10Overall Score
NeturalInvestment Rating
3.52 / 10Overall Score
NeturalInvestment Rating
Is RNAC a Buy, Sell, or Hold?
- Based on a composite score of 3.52/10, we rate RNAC as a Netural. Our analysis breaks down into 3.39/10 for Fundamentals, 1.28/10 for Technicals, and 4.71/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of RNAC?
Is RNAC undervalued or overvalued?
What is the analyst consensus for RNAC?
Is RNAC a Buy, Sell, or Hold?
- Based on a composite score of 3.52/10, we rate RNAC as a Netural. Our analysis breaks down into 3.39/10 for Fundamentals, 1.28/10 for Technicals, and 4.71/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is RNAC undervalued or overvalued?
Technical Analysis of RNAC?
What is the analyst consensus for RNAC?
